Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001396415) titled 'A safety and feasibility study of the delivery of energy pulses within the intestine' on Dec. 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Ascend Clinical Research Organization, Pty Ltd.
Condition:
Type 2 Diabetes
Type 2 Diabetes
Metabolic and Endocrine - Diabetes
Intervention:
This is a prospective, single-arm, single centre, interventional study evaluating the safety of a new device designed for the delivery of a low energy pulse to part of th...